Back to 2015 Annual Meeting Posters
VATS lobectomy is beneficial in patient with poor pulmonary lung function for stage I lung cancer.
jong ho cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Jhingook Kim, Young Mog Shim.
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, seoul, Korea, Republic of.
OBJECTIVE: It is not clear whether VATS lobectomy is beneficial in patients with poor pulmonary lung function.
The aim of our study is to evaluate the postoperative outcome and long-term outcomes of patients with poor lung function who underwent thoracoscopic lobectomy for pathologic stage I non-small cell lung cancer (NSCLC).
METHODS: The patients who underwent lobectomy by either thoracotomy or VATS for pathologic stage I NSCLC were retrospectively reviewed. The predicted postoperative (ppo) parameters of forced expiratory volume in 1 second (ppoFEV1) and diffusing capacity of the lung for carbon monoxide (ppoDLCO) were calculated for patients who underwent lobectomy. We divided the patients depending on ppoFEV1% (Group 1: 80%) and ppoDLCO% (Group A: 80%). Data were analyzed with respect to demographics, risk factors, and early postoperative outcome and survival according to ppoFEV1% and ppoDLCO%.
RESULTS: From 2007 to 2008, 244 patients with pathologic stage I NSCLC underwent lobectomy (open, n=62 ; VATS ,n=182). A median follow-up duration period was 53.3 months (range, 1 to 102). The overall survival rate at 5 years was 80.6%. The perioperative mortality rate (within 60 days from surgery) was 6.5% (4/62) in open group and 2.2% (4/182) in VATS group. The overall morbidity rate was 27.4 % (17/62) in open group and 25.8 % (47/182) in VATS group (p=0.879). The rate of cardiopulmonary complications was 19.4 % (12/62) in open group and 16.5 % (30/182) in VATS group. With decreasing ppo FEV1%, the cardiopulmonary complication increased at a greater rate in the open group than in the VATS group (Figure 1). However, there was no relationship between ppoDLCO% and cardiopulmonary complications.
CONCLUSIONS: Video-assisted thoracic lobectomy for cancer in patients with poor lung function can achieve acceptable postoperative outcome and oncologic outcome compared to open thoracotomy.
Back to 2015 Annual Meeting Posters




